[Research progress on penis cavernosa fibrosis].
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or original human data
What was done
This narrative review summarizes research developments in the diagnosis and treatment of penile cavernosa fibrosis, a key driver of refractory erectile dysfunction. It focuses on diagnostic advances such as two-dimensional shear wave elastography (2D-SWE) and molecular imaging, alongside potential therapeutic approaches including stem cell therapy, energy-based treatments, targeted therapy, and traditional Chinese medicine.
What was found
The abstract provides no numerical data, statistics, or effect sizes. It qualitatively reports that 2D-SWE and molecular imaging offer possibilities for early diagnosis, grading, and staging of fibrosis, and notes that stem cell therapy, energy-based therapies, targeted therapy, and traditional Chinese medicine demonstrate promising anti-fibrotic potential.
Why it matters
Penile cavernosa fibrosis leads to erectile dysfunction that does not respond well to conventional therapies. Tracking emerging diagnostic tools and experimental interventions helps outline future clinical and research pathways for refractory cases.
Limits
As a narrative review, no original data, sample sizes, or systematic search methodologies are reported. The abstract provides no quantitative measures of clinical efficacy, safety profiles, or comparative outcomes for any of the discussed interventions.
Cited by
- supports Long-term metabolic dysfunction and vascular disease lead to penile atrophy and size loss.